Sichuan Hebang Biotechnology Stock Short Ratio
| 603077 Stock | 1.95 0.03 1.52% |
Sichuan Hebang Biotechnology fundamentals help investors to digest information that contributes to Sichuan Hebang's financial success or failures. It also enables traders to predict the movement of Sichuan Stock. The fundamental analysis module provides a way to measure Sichuan Hebang's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sichuan Hebang stock.
Sichuan | Short Ratio |
Sichuan Hebang Biotechnology Company Short Ratio Analysis
Sichuan Hebang's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Sichuan Hebang Biotechnology has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Chemicals sector and about the same as Materials (which currently averages 0.0) industry. The short ratio for all China stocks is 100.0% higher than that of the company.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Sichuan Fundamentals
| Return On Equity | 0.0231 | |||
| Return On Asset | 0.0139 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 18.09 B | |||
| Shares Outstanding | 8.83 B | |||
| Shares Owned By Insiders | 35.55 % | |||
| Shares Owned By Institutions | 2.71 % | |||
| Price To Book | 0.92 X | |||
| Price To Sales | 1.87 X | |||
| Revenue | 8.82 B | |||
| Gross Profit | 5.55 B | |||
| EBITDA | 1.61 B | |||
| Net Income | 1.28 B | |||
| Total Debt | 1.17 B | |||
| Book Value Per Share | 2.34 X | |||
| Cash Flow From Operations | 80.33 M | |||
| Earnings Per Share | 0.06 X | |||
| Target Price | 6.0 | |||
| Number Of Employees | 7.17 K | |||
| Beta | 0.33 | |||
| Market Capitalization | 17.22 B | |||
| Total Asset | 24.54 B | |||
| Retained Earnings | 9.61 B | |||
| Working Capital | 6.18 B | |||
| Net Asset | 24.54 B |
About Sichuan Hebang Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sichuan Hebang Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sichuan Hebang using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sichuan Hebang Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Sichuan Stock
Sichuan Hebang financial ratios help investors to determine whether Sichuan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sichuan with respect to the benefits of owning Sichuan Hebang security.